Statistics by Country for Myasthenia Gravis
|
About these extrapolations of prevalence and incidence statistics for Myasthenia Gravis:
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of Myasthenia Gravis are typically based on US, UK, Canadian or Australian statistics.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated Myasthenia Gravis statistics below refer to.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of Myasthenia Gravis in that region.
About prevalence and incidence statistics in general for Myasthenia Gravis: The word 'prevalence' of Myasthenia Gravis usually means the estimated population of people who are managing Myasthenia Gravis at any given time (i.e. people with Myasthenia Gravis). The term 'incidence' of Myasthenia Gravis means the annual diagnosis rate, or the number of new cases of Myasthenia Gravis diagnosed each year (i.e. getting Myasthenia Gravis). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics. |
Prevalance of Myasthenia Gravis: about 5 per 100,000 to 14 per 100,000 (NWHIC)
Prevalance Rate for Myasthenia Gravis: approx 1 in 20,000 or 0.00% or 13,600 people in USA [about data]
Extrapolation of Prevalence Rate of Myasthenia Gravis to Countries and Regions: The following table attempts to extrapolate the above prevalence rate for Myasthenia Gravis to the populations of various countries and regions. As discussed above, these prevalence extrapolations for Myasthenia Gravis are only estimates and may have limited relevance to the actual prevalence of Myasthenia Gravis in any region:
| Country/Region | Extrapolated Prevalence | Population Estimated Used |
| Myasthenia Gravis in North America (Extrapolated Statistics) | ||
| USA | 14,682 | 293,655,4051 |
| Canada | 1,625 | 32,507,8742 |
| Myasthenia Gravis in Europe (Extrapolated Statistics) | ||
| Austria | 408 | 8,174,7622 |
| Belgium | 517 | 10,348,2762 |
| Britain (United Kingdom) | 3,013 | 60,270,708 for UK2 |
| Czech Republic | 62 | 1,0246,1782 |
| Denmark | 270 | 5,413,3922 |
| Finland | 260 | 5,214,5122 |
| France | 3,021 | 60,424,2132 |
| Greece | 532 | 10,647,5292 |
| Germany | 4,121 | 82,424,6092 |
| Iceland | 14 | 293,9662 |
| Hungary | 501 | 10,032,3752 |
| Liechtenstein | 1 | 33,4362 |
| Ireland | 198 | 3,969,5582 |
| Italy | 2,902 | 58,057,4772 |
| Luxembourg | 23 | 462,6902 |
| Monaco | 1 | 32,2702 |
| Netherlands (Holland) | 815 | 16,318,1992 |
| Poland | 1,931 | 38,626,3492 |
| Portugal | 526 | 10,524,1452 |
| Spain | 2,014 | 40,280,7802 |
| Sweden | 449 | 8,986,4002 |
| Switzerland | 372 | 7,450,8672 |
| United Kingdom | 3,013 | 60,270,7082 |
| Wales | 145 | 2,918,0002 |
| Myasthenia Gravis in the Balkans (Extrapolated Statistics) | ||
| Albania | 177 | 3,544,8082 |
| Bosnia and Herzegovina | 20 | 407,6082 |
| Croatia | 224 | 4,496,8692 |
| Macedonia | 102 | 2,040,0852 |
| Serbia and Montenegro | 541 | 10,825,9002 |
| Myasthenia Gravis in Asia (Extrapolated Statistics) | ||
| Bangladesh | 7,067 | 141,340,4762 |
| Bhutan | 109 | 2,185,5692 |
| China | 64,942 | 1,298,847,6242 |
| East Timor | 50 | 1,019,2522 |
| Hong Kong s.a.r. | 342 | 6,855,1252 |
| India | 53,253 | 1,065,070,6072 |
| Indonesia | 11,922 | 238,452,9522 |
| Japan | 6,366 | 127,333,0022 |
| Laos | 303 | 6,068,1172 |
| Macau s.a.r. | 22 | 445,2862 |
| Malaysia | 1,176 | 23,522,4822 |
| Mongolia | 137 | 2,751,3142 |
| Philippines | 4,312 | 86,241,6972 |
| Papua New Guinea | 271 | 5,420,2802 |
| Vietnam | 4,133 | 82,662,8002 |
| Singapore | 217 | 4,353,8932 |
| Pakistan | 7,959 | 159,196,3362 |
| North Korea | 1,134 | 22,697,5532 |
| South Korea | 2,411 | 48,233,7602 |
| Sri Lanka | 995 | 19,905,1652 |
| Taiwan | 1,137 | 22,749,8382 |
| Thailand | 3,243 | 64,865,5232 |
| Myasthenia Gravis in Eastern Europe (Extrapolated Statistics) | ||
| Azerbaijan | 393 | 7,868,3852 |
| Belarus | 515 | 10,310,5202 |
| Bulgaria | 375 | 7,517,9732 |
| Estonia | 67 | 1,341,6642 |
| Georgia | 234 | 4,693,8922 |
| Kazakhstan | 757 | 15,143,7042 |
| Latvia | 115 | 2,306,3062 |
| Lithuania | 180 | 3,607,8992 |
| Romania | 1,117 | 22,355,5512 |
| Russia | 7,198 | 143,974,0592 |
| Slovakia | 271 | 5,423,5672 |
| Slovenia | 100 | 2,011,473 2 |
| Tajikistan | 350 | 7,011,556 2 |
| Ukraine | 2,386 | 47,732,0792 |
| Uzbekistan | 1,320 | 26,410,4162 |
| Myasthenia Gravis in Australasia and Southern Pacific (Extrapolated Statistics) | ||
| Australia | 995 | 19,913,1442 |
| New Zealand | 199 | 3,993,8172 |
| Myasthenia Gravis in the Middle East (Extrapolated Statistics) | ||
| Afghanistan | 1,425 | 28,513,6772 |
| Egypt | 3,805 | 76,117,4212 |
| Gaza strip | 66 | 1,324,9912 |
| Iran | 3,375 | 67,503,2052 |
| Iraq | 1,268 | 25,374,6912 |
| Israel | 309 | 6,199,0082 |
| Jordan | 280 | 5,611,2022 |
| Kuwait | 112 | 2,257,5492 |
| Lebanon | 188 | 3,777,2182 |
| Libya | 281 | 5,631,5852 |
| Saudi Arabia | 1,289 | 25,795,9382 |
| Syria | 900 | 18,016,8742 |
| Turkey | 3,444 | 68,893,9182 |
| United Arab Emirates | 126 | 2,523,9152 |
| West Bank | 115 | 2,311,2042 |
| Yemen | 1,001 | 20,024,8672 |
| Myasthenia Gravis in South America (Extrapolated Statistics) | ||
| Belize | 13 | 272,9452 |
| Brazil | 9,205 | 184,101,1092 |
| Chile | 791 | 15,823,9572 |
| Colombia | 2,115 | 42,310,7752 |
| Guatemala | 714 | 14,280,5962 |
| Mexico | 5,247 | 104,959,5942 |
| Nicaragua | 267 | 5,359,7592 |
| Paraguay | 309 | 6,191,3682 |
| Peru | 1,377 | 27,544,3052 |
| Puerto Rico | 194 | 3,897,9602 |
| Venezuela | 1,250 | 25,017,3872 |
| Myasthenia Gravis in Africa (Extrapolated Statistics) | ||
| Angola | 548 | 10,978,5522 |
| Botswana | 81 | 1,639,2312 |
| Central African Republic | 187 | 3,742,4822 |
| Chad | 476 | 9,538,5442 |
| Congo Brazzaville | 149 | 2,998,0402 |
| Congo kinshasa | 2,915 | 58,317,0302 |
| Ethiopia | 3,566 | 71,336,5712 |
| Ghana | 1,037 | 20,757,0322 |
| Kenya | 1,649 | 32,982,1092 |
| Liberia | 169 | 3,390,6352 |
| Niger | 568 | 11,360,5382 |
| Nigeria | 887 | 12,5750,3562 |
| Rwanda | 411 | 8,238,6732 |
| Senegal | 542 | 10,852,1472 |
| Sierra leone | 294 | 5,883,8892 |
| Somalia | 415 | 8,304,6012 |
| Sudan | 1,957 | 39,148,1622 |
| South Africa | 2,222 | 44,448,4702 |
| Swaziland | 58 | 1,169,2412 |
| Tanzania | 1,803 | 36,070,7992 |
| Uganda | 1,319 | 26,390,2582 |
| Zambia | 551 | 11,025,6902 |
| Zimbabwe | 183 | 1,2671,8602 |
Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004
Last revision: June 4, 2003
Medical Tools & Articles:
Next articles:
Medical Articles: